Prestige Consumer Healthcare elects John F. Kelly, former Pfizer VP, to Board

Prestige Consumer Healthcare Inc.

John F. Kelly, former Vice President Quality Operations and EHS at Pfizer, elected to PBH Board on May 7, 2024.
Appointed to Compensation and Talent Management and Nominating and Corporate Governance Committees.
Kelly retired in 2022 after 40-year career at Pfizer, including leading global quality and EHS functions.
No related party transactions or arrangements in connection with his appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John F. Kelly

Director

PBH · Prestige Consumer Healthcare Inc.

Effective: 2024-05-07
Filed: May 8, 2024, 7:59 PM ET

The Company today announced that John F. Kelly, former Vice President Quality Operations and Environment, Health & Safety at Pfizer Inc. was elected to the Company’s Board of Directors on May 7, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John F. Kelly was elected as Director at Prestige Consumer Healthcare Inc..

Action: elected
Role: Director

Exact text from the filing

The Company today announced that John F. Kelly, former Vice President Quality Operations and Environment, Health & Safety at Pfizer Inc. was elected to the Company’s Board of Directors on May 7, 2024.

View on SEC.gov

Prestige Consumer Healthcare Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-058841

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.